Pathways analysis of molecular markers in chronic sinusitis with polyps

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 5, 2011, Pages 802-808

  Platt, Michael P ^a,b,c   Soler, Zachary ^b,c   Metson, Ralph ^b,c   Stankovic, Konstantina M ^b,c  

^a BOSTON MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Bioinformatics; Chronic sinusitis; Gene; Genetics; Nasal polyposis; Nasal polyps; Pathways; Polyps; Sinusitis

Indexed keywords

CYTOKINE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MOLECULAR MARKER; PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

ARTICLE; BIOINFORMATICS; CHRONIC SINUSITIS; ENVIRONMENTAL FACTOR; ETHMOID SINUS; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; NOSE POLYP; PATHOGENESIS; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; CHRONIC DISEASE; GENETICS; REVIEW; SINUSITIS;

CHRONIC DISEASE; GENE EXPRESSION PROFILING; HUMANS; NASAL POLYPS; SINUSITIS;

EID: 80051712062     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810395091     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention (CDC). CDC Summary Health Statistics for US Adults: National Health Information Survey, 2006. Atlanta, GA: CDC; 2006.
2. Settipane GA. Epidemiology of nasal polyps. Allergy Asthma Proc. 1996;17:231-236. (Pubitemid 26403402)
3. Stankovic KM, Goldsztein H, Reh DD, Platt MP, Metson R. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope. 2008;118:881-889. (Pubitemid 351674119)
4. Ingenuity Systems. www.Ingenuity.com. Accessed September 19, 2010.
5. Pouliot P, Olivier M. Opposing forces in asthma: regulation of signaling pathways by kinases and phosphatases. Crit Rev Immunol. 2009;29:419-442.
6. Chung KF, Marwick JA. Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease. Ann N Y Acad Sci. 2010;1203:85-91.
7. Teixeiro E, Daniels MA. ERK and cell death: ERK location and T cell selection. FEBS J. 2010;277:30-38.
8. Lin SK, Kok SH, Shun CT, et al. Tumor necrosis factor-alpha stimulates the expression of C-C chemokine ligand 2 gene in fibroblasts from the human nasal polyp through the pathways of mitogen-activated protein kinase. Am J Rhinol. 2007;21:251-255.
9. Raia V, Maiuri L, Ciacci C, et al. Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis. Thorax. 2005;60:773-780. (Pubitemid 41297898)
10. Wang Z, Zhang Q, Li Y, et al. Involvement of mitogen-activated protein kinases and nuclear factor kappa B pathways in signaling COX-2 expression in chronic rhinosinusitis. Inflamm Res. 2009;58:649-658.
11. Adcock IM, Chung KF, Caramori G, Ito K. Kinase inhibitors and airway inflammation. Eur J Pharmacol. 2006;533:118-132. (Pubitemid 43340009)
12. Barnes PJ. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2009;6:693-696.
13. Valera FC, Queiroz R, Scrideli C. Expression of transcription factors NF-kappaB and AP-1 in nasal polyposis. Clin Exp Allergy. 2008;8:579-585. (Pubitemid 351406065)
14. Xu R, Xu G, Shi J, Wen W. A correlative study of NF-kappaB activity and cytokines expression in human chronic nasal sinusitis. J Laryngol Otol. 2007;121:644-649. (Pubitemid 47014195)
15. Swamy M, Jamora C, Havran W, Hayday A. Epithelial decision makers: in search of the 'epimmunome.' Nat Immunol. 2010;11:656-665.
16. Boyce BF, Yao Z, Xing L. Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci. 2010;1192:367-375.
17. Wullaert A. Role of NF-kappaB activation in intestinal immune homeostasis. Int J Med Microbiol. 2010;300:49-56.
18. Janssen-Heininger YM, Poynter ME, Aesif SW, et al. Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proc Am Thorac Soc. 2009;6:249-255.
19. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J Cell Sci. 2004;117:5965-5973. (Pubitemid 40123963)
20. Li CW, Cheung W, Lin ZB, Lim JT, Wang DY. Oral steroids enhance repair in nasal polyposis via upregulation of the AP-1 gene network. Thorax. 2009;64:306-312.
21. Edwards MR, Bartlett NW, Clarke D, et al. Targeting the NFkappaB pathway in asthma and chronic obstructive pulmonary disease. Pharmacol Ther. 2009;121:1-13.
22. Lee HS, Myers A, Kim J. Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. Am J Resp Crit Care Med. 2009;180:1056-1067.
23. Otto BA, Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg. 2008;16:270-274. (Pubitemid 351677664)
24. Furst DE. Development of TNF inhibitor therapies for the treatment of rheumatoid arthritis. Clin Exp Rheumatol. 2010;28(3) (suppl 59):S5-S12.
25. Miteva M. Psoriasis: targeting therapy towards the inflammatory cascade. Am J Clin Dermatol. 2010;11(suppl 1):11-13.
26. Monteleone G, Caprioli F. T-cell-directed therapies in inflammatory bowel diseases. Clin Sci. 2010;118:707-715.